Lincoln Pharmaceuticals Ltd - 531633 - Intimation Of Book Closure And Record Date For The Purpose Of 32Nd Annual General Meeting And Final Dividend For The Financial Year 2025-26.BSE filing · raw filing ↗
29 Aug 2026
⚑ Filing
Lincoln Pharmaceuticals Ltd - 531633 - Corporate Action-Fixes Book Closure For Determining The Dividend, If Approved At The AGMBSE filing · raw filing ↗
26 Aug 2026
⚑ Filing
Copy of Newspaper PublicationNSE filing · raw filing ↗
26 Aug 2026
⚑ Filing
Lincoln Pharmaceuticals Ltd - 531633 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE filing · raw filing ↗
14 Aug 2026
⚑ Filing
Copy of Newspaper PublicationNSE filing · raw filing ↗
14 Aug 2026
⚑ Filing
Lincoln Pharmaceuticals Ltd - 531633 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE filing · raw filing ↗
Q4 FY26 results filed — revenue ₹187 Cr (+11.4% YoY), PAT ₹12 Cr (+0.5% YoY)NSE filing · raw filing ↗
Ex-date 12 Sep 2025
⚑ Corp action
Dividend — ₹1.80 per shareNSE filing · record 12 Sep 2025
Ex-date 13 Sep 2024
⚑ Corp action
Dividend — ₹1.80 per shareNSE filing
Ex-date 15 Sep 2023
⚑ Corp action
Dividend — ₹1.50 per shareNSE filing
Ex-date 15 Sep 2022
⚑ Corp action
Dividend — ₹1.50 per shareNSE filing
Ex-date 16 Sep 2021
⚑ Corp action
Dividend — ₹1.50 per shareNSE filing
Ex-date 5 Mar 2020
⚑ Corp action
Dividend — ₹1.50 per shareNSE filing · record 6 Mar 2020
Ex-date 19 Sep 2019
⚑ Corp action
Dividend — ₹1.50 per shareNSE filing
Ex-date 19 Sep 2018
⚑ Corp action
Dividend — ₹1.50 per shareNSE filing
Ex-date 21 Sep 2017
⚑ Corp action
Dividend — ₹1.20 per shareNSE filing
Ex-date 23 Sep 2016
⚑ Corp action
Dividend — ₹1.00 per shareNSE filing
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
